Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. | Cell Rep | 2023 | 37494188 | PubTator, text mining | PubMed |
| Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy? | Genes Dis | 2023 | 37492721 | PubTator, text mining | PubMed |
| Leveraging translational insights toward precision medicine approaches for brain metastases. | Nat Cancer | 2023 | 37491527 | PubTator, text mining | PubMed |
| GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. | J Hematol Oncol | 2023 | 37475048 | PubTator, text mining | PubMed |
| Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target. | Front Oncol | 2023 | 37469409 | PubTator, text mining | PubMed |
| Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway. | BMC Prim Care | 2023 | 37468831 | PubTator, text mining | PubMed |
| The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion? | Int J Mol Sci | 2023 | 37446290 | PubTator, text mining | PubMed |
| Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment. | Int J Mol Sci | 2023 | 37445973 | PubTator, text mining | PubMed |
| SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model. | Cells | 2023 | 37443832 | PubTator, text mining | PubMed |
| Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy. | Int Rev Cell Mol Biol | 2023 | 37438018 | PubTator, text mining | PubMed |
| IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. | Sci Adv | 2023 | 37436978 | PubTator, text mining | PubMed |
| A new compact adenine base editor generated through deletion of HNH and REC2 domain of SpCas9. | BMC Biol | 2023 | 37434184 | PubTator, text mining | PubMed |
| Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations. | PLoS One | 2023 | 37432935 | PubTator, text mining | PubMed |
| Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors. | JTO Clin Res Rep | 2023 | 37426308 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma. | Cancer Metastasis Rev | 2023 | 37422534 | PubTator, text mining | PubMed |
| Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity. | Int J Biol Sci | 2023 | 37416780 | PubTator, text mining | PubMed |
| Tumor-associated myeloid cells in cancer immunotherapy. | J Hematol Oncol | 2023 | 37415162 | PubTator, text mining | PubMed |
| Diagnostic Efficacy and Possible Underlying Mechanisms of Noninvasive Clinical Markers in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37408805 | PubTator, text mining | PubMed |
| Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials. | Front Aging Neurosci | 2023 | 37396657 | PubTator, text mining | PubMed |
| AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis. | Front Endocrinol (Lausanne) | 2023 | 37396176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=17